Literature DB >> 16670395

Persistent pulmonary hypertension of the newborn and maternal use of SSRIs.

Eric Wooltorton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16670395      PMCID： PMC1459897          DOI： 10.1503/cmaj.060509

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

Review 1.  Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?

Authors:  Gideon Koren; Doreen Matsui; Adrienne Einarson; David Knoppert; Meir Steiner
Journal:  CMAJ       Date:  2005-05-24       Impact factor: 8.262

2.  Paroxetine (Paxil) and congenital malformations.

Authors:  Megan Williams; Eric Wooltorton
Journal:  CMAJ       Date:  2005-11-04       Impact factor: 8.262

3.  Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn.

Authors:  Christina D Chambers; Sonia Hernandez-Diaz; Linda J Van Marter; Martha M Werler; Carol Louik; Kenneth Lyons Jones; Allen A Mitchell
Journal:  N Engl J Med       Date:  2006-02-09       Impact factor: 91.245
  3 in total
  1 in total

Review 1.  Investigating outcomes following the use of selective serotonin reuptake inhibitors for treating depression in pregnancy: a focus on methodological issues.

Authors:  Luke E Grzeskowiak; Andrew L Gilbert; Janna L Morrison
Journal:  Drug Saf       Date:  2011-11-01       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.